Shots:
- Chai Discovery has entered a collaboration with BMS to advance the discovery of therapeutic antibodies using artificial intelligence
- As per the deal, BMS will leveraging Chai’s AI models and platform capabilities including its molecular folding & design models to support the discovery of antibody candidates across its portfolio and to support the development of a continuously learning, AI-powered discovery system
- Chai’s models are designed to evaluate biological structure and function, generate new molecular designs, and help pharmaceutical teams investigate targets that have proven difficult to address with traditional methods
Ref: Businesswire | Image: Chai Discovery & BMS | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect@pharmashots.com
